460 related articles for article (PubMed ID: 17487860)
1. Risk factors for infections with multidrug-resistant Stenotrophomonas maltophilia in patients with cancer.
Ansari SR; Hanna H; Hachem R; Jiang Y; Rolston K; Raad I
Cancer; 2007 Jun; 109(12):2615-22. PubMed ID: 17487860
[TBL] [Abstract][Full Text] [Related]
2. Stenotrophomonas (Xanthomonas) maltophilia: a multidrug-resistant nosocomial pathogen.
Penzak SR; Abate BJ
Pharmacotherapy; 1997; 17(2):293-301. PubMed ID: 9085321
[TBL] [Abstract][Full Text] [Related]
3. Emerging importance of multidrug-resistant Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients: geographic patterns, epidemiological features, and trends in the SENTRY Antimicrobial Surveillance Program (1997-1999).
Gales AC; Jones RN; Forward KR; Liñares J; Sader HS; Verhoef J
Clin Infect Dis; 2001 May; 32 Suppl 2():S104-13. PubMed ID: 11320451
[TBL] [Abstract][Full Text] [Related]
4. [Nosocomial Stenotrophomonas maltophilia infections in a university hospital].
Caylan R; Yilmaz G; Sucu N; Bayraktar O; Aydin K; Kaklikkaya N; Aydin F; Köksal I
Mikrobiyol Bul; 2005 Jan; 39(1):25-33. PubMed ID: 15900834
[TBL] [Abstract][Full Text] [Related]
5. A multicenter surveillance of antimicrobial resistance on Stenotrophomonas maltophilia in Taiwan.
Wu H; Wang JT; Shiau YR; Wang HY; Lauderdale TL; Chang SC;
J Microbiol Immunol Infect; 2012 Apr; 45(2):120-6. PubMed ID: 22154599
[TBL] [Abstract][Full Text] [Related]
6. Optimizing therapy for Stenotrophomonas maltophilia.
Muder RR
Semin Respir Crit Care Med; 2007 Dec; 28(6):672-7. PubMed ID: 18095231
[TBL] [Abstract][Full Text] [Related]
7. Intensive care unit-acquired Stenotrophomonas maltophilia: incidence, risk factors, and outcome.
Nseir S; Di Pompeo C; Brisson H; Dewavrin F; Tissier S; Diarra M; Boulo M; Durocher A
Crit Care; 2006; 10(5):R143. PubMed ID: 17026755
[TBL] [Abstract][Full Text] [Related]
8. Stenotrophomonas maltophilia: changing spectrum of a serious bacterial pathogen in patients with cancer.
Safdar A; Rolston KV
Clin Infect Dis; 2007 Dec; 45(12):1602-9. PubMed ID: 18190323
[TBL] [Abstract][Full Text] [Related]
9. Extensively drug-resistant Stenotrophomonas maltophilia in a tertiary care hospital in Taiwan: microbiologic characteristics, clinical features, and outcomes.
Tan CK; Liaw SJ; Yu CJ; Teng LJ; Hsueh PR
Diagn Microbiol Infect Dis; 2008 Feb; 60(2):205-10. PubMed ID: 17950557
[TBL] [Abstract][Full Text] [Related]
10. Stenotrophomonas maltophilia and antibiotic use in German intensive care units: data from Project SARI (Surveillance of Antimicrobial Use and Antimicrobial Resistance in German Intensive Care Units).
Meyer E; Schwab F; Gastmeier P; Rueden H; Daschner FD; Jonas D
J Hosp Infect; 2006 Nov; 64(3):238-43. PubMed ID: 16979794
[TBL] [Abstract][Full Text] [Related]
11. Community-acquired infection due to Stenotrophomonas maltophilia: a rare cause of septic arthritis.
Aydemir C; Aktaş E; Eldeş N; Kutsal E; Demirel F; Ege A
Turk J Pediatr; 2008; 50(1):89-90. PubMed ID: 18365601
[TBL] [Abstract][Full Text] [Related]
12. Which patient is a candidate for empirical therapy against Stenotrophomonas maltophilia bacteraemia? An analysis of associated risk factors in a tertiary care hospital.
Metan G; Hayran M; Hascelik G; Uzun O
Scand J Infect Dis; 2006; 38(6-7):527-31. PubMed ID: 16798705
[TBL] [Abstract][Full Text] [Related]
13. The emergence of Stenotrophomonas maltophilia as a significant nosocomial pathogen at the University Hospital of the West Indies.
Nicholson AM; Castle D; Akpaka P; Tennant I; Nelson M
West Indian Med J; 2004 Jan; 53(1):17-22. PubMed ID: 15114888
[TBL] [Abstract][Full Text] [Related]
14. Stenotrophomonas maltophilia bacteremia in pediatric patients-- a 10-year analysis.
Wu PS; Lu CY; Chang LY; Hsueh PR; Lee PI; Chen JM; Lee CY; Chan PC; Chang PY; Yang TT; Huang LM
J Microbiol Immunol Infect; 2006 Apr; 39(2):144-9. PubMed ID: 16604247
[TBL] [Abstract][Full Text] [Related]
15. Clinical characteristics of Stenotrophomonas maltophilia meningitis in adults: a high incidence in patients with a postneurosurgical state, long hospital staying and antibiotic use.
Huang CR; Chen SF; Tsai NW; Chang CC; Lu CH; Chuang YC; Chien CC; Chang WN
Clin Neurol Neurosurg; 2013 Sep; 115(9):1709-15. PubMed ID: 23611735
[TBL] [Abstract][Full Text] [Related]
16. Rates of Stenotrophomonas maltophilia colonization and infection in relation to antibiotic cycling protocols.
Pakyz AL; Farr BM
Epidemiol Infect; 2009 Dec; 137(12):1679-83. PubMed ID: 19874637
[TBL] [Abstract][Full Text] [Related]
17. Antibiotic combinations significantly more active than monotherapy in an in vitro infection model of Stenotrophomonas maltophilia.
Zelenitsky SA; Iacovides H; Ariano RE; Harding GK
Diagn Microbiol Infect Dis; 2005 Jan; 51(1):39-43. PubMed ID: 15629227
[TBL] [Abstract][Full Text] [Related]
18. [Molecular epidemiology of Stenotrophomonas maltophilia strains isolated from paediatric patients].
Köseoğlu O; Sener B; Gür D
Mikrobiyol Bul; 2004; 38(1-2):9-19. PubMed ID: 15293897
[TBL] [Abstract][Full Text] [Related]
19. Risk factors and clinical characteristics of Stenotrophomonas maltophilia infections in neonates.
Mutlu M; Yılmaz G; Aslan Y; Bayramoğlu G
J Microbiol Immunol Infect; 2011 Dec; 44(6):467-72. PubMed ID: 21606009
[TBL] [Abstract][Full Text] [Related]
20. [Surveillance on antibiotic resistance of Stenotrophomonas maltophilia in Chengdu and Chongqing area].
Tao CM; Li XC; Lü XJ; Li P; Yu RJ; Gao YY; Chen HL
Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Jan; 35(1):91-3. PubMed ID: 14981826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
